|
|
 |
December News
Myelin News
December 26th, 2011
By LAURIE TARKAN
Published: December 26, 2011
Three years ago, Kristie Salerno Kent, a singer-songwriter, was standing in a security line at the airport on her way home from a gig when her legs went numb. “From the waist down, it felt as though I was trying to walk through a bowl of oatmeal,” said the 38-year-old musician, who has multiple sclerosis. Read more...
December 23rd, 2011
Through her research into MS, Dr. Wahls discovered that, for some unknown reason, in addition to the commonly known symptoms, MS patients' brains also tend to shrink. This roused her curiosity, and led her to research other diseases that have similar brain shrinkage, namely Huntington's, Parkinson's and Alzheimer's Disease. One common denominator is poorly functioning mitochondria. Mitochondria are like little 'batteries' in your cells that manage the energy supply to the cell, and unless you consume the correct nutrients, eventual mitochondrial malfunction is the obvious result. Read more...
December 20th, 2011
Published on Tuesday, December 20th, 2011 |
LORENZO Odone’s fighting spirit lives on in East Yorkshire. Millions of people who have never set foot inside a natural chemical plant will have heard of Croda International because of Lorenzo’s Oil.
Today, Croda is building on its rich heritage by creating jobs and developing the cosmetics of the future. Croda is investing £11m to build a new manufacturing plant to make acrylic polymers, a development which will be of interest to everyone who uses skin creams and household cleaning products. Read more...
December 19th, 2011
Wine's ability to ease inflammation may help slow the progression of multiple sclerosis (MS) in some cases, according to a study by researchers from neurology and psychology clinics in Belgium. The team found that patients who suffer from the so-called relapse form of MS and also drank wine had less severe symptoms. But the impact of wine was limited and the reasons for the effects were unclear. Read more...
December 17th, 2011
BY KRISTA CONGER - Two months ago, 23-year-old Katie Sharify, a former student at the University of Southern California majoring in international relations and communications, knew very little about human embryonic stem cell research. But now she’s a vocal advocate for the field, which sparks outrage in some circles with its reliance on cells derived from human embryos.
MS Society Awareness Talk: MS research breakthroughs in myelin repair
-
Professor Robin Franklin explains the ground-breaking work he and his team at the Cambridge Centre for Myelin Repair are doing to find a treatment for all types of MS.
-
Get an update on MS Society work and getting involved in research
-
Hear from a member of the MS Society Research Network
-
13 Feb 2012 at 6:30PM - 8:30PM
-
Mercure Hotel, Swansea
-
SA7 9EG
-
FREE and open to all affected by MS
December 16th, 2011
Published: Dec 14, 2011 10:44 pm
A new medication for multiple sclerosis just got one step closer to being available for use. Researchers have published data that they believe shows exactly how the drug works in the brain.
December 13th, 2011
Published: Dec 12, 2011 01:56 pm
Multiple sclerosis manifests in a wide range of symptoms, from difficulty with balance to fatigue and vision problems. These problems all originate in the brain, but how?
New research has found that multiple sclerosis (MS) progresses through the brain by taking a different path than previously thought. The theory was that MS begins in the myelin deep inside the brain, the sheath that covers and protects the nerve cells. Read more...
December 7th, 2011
Working together, researchers at Cleveland Clinic and Mayo Clinic have for the first time examined early multiple sclerosis (MS) brain lesions in the cerebral cortex. These lesions are thought to be critical to MS progression and the researchers found that the lesions are distinctly different than previously speculated, giving clues to better disease management. Read more...
December 6th, 2011
By Eric Gershon | 07/12/2011
Researchers at Yale University have developed a novel nanoparticle with promising applications in gene therapy, a type of medical treatment that addresses the root causes of diseases now typically treated for symptoms. Read more...
December 4th, 2011
British doctors are to conduct a trial using bone marrow stem cells that they hope could halt or perhaps even reverse the progression of multiple sclerosis (MS). Read More...
December 2nd, 2011
Rochester Business Journal
December 2, 2011
The National Multiple Sclerosis Society has committed more than $850,000 for a grant to a University of Rochester Medical Center researcher. It is part of $16 million from the group to support 32 new MS research projects. Read more...
|
|
|
|
OPML |
Search This Site |
Home
Share
